To the top

Page Manager: Webmaster
Last update: 4/19/2017 1:56 PM

Tell a friend about this page
Print version

Ali Harandi - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

Ali Harandi


Ali Harandi
+46 31 786 6229

Postal Address: Box 435, 40530 Göteborg
Visiting Address: Medicinaregatan 7A, vån 3 , 41390 Göteborg

Department of Microbiology and Immunology at Institute of Biomedicine (More Information)
Box 435
405 30 Göteborg
Fax: +46 31 786 6210
Visiting Address: Medicinaregatan 7 A , 413 90 Göteborg

Latest publications

Profiling inflammatory response in lesions of cutaneous leishmaniasis patients using a non-invasive sampling method combined with a high-throughput protein detection assay
Y. Taslimi, Christopher Agbajogu, S. F. Brynjolfsson, N. Masoudzadeh, V. Mashayekhi et al.
Cytokine, Journal article 2020
Journal article

Metabolic Profiling and Compound-Class Identification Reveal Alterations in Serum Triglyceride Levels in Mice Immunized with Human Vaccine Adjuvant Alum.
Sakda Khoomrung, Intawat Nookaew, Partho Sen, Thorunn A Olafsdottir, Josefine Persson et al.
Journal of proteome research, Journal article 2020
Journal article

Systems analysis of human vaccine adjuvants
Ali M Harandi
Seminars in Immunology, Journal article 2018
Journal article

Biomarkers of Cutaneous Leishmaniasis
F. Bahrami, Ali M Harandi, S. Riafati
Frontiers in Cellular and Infection Microbiology, Journal article 2018
Journal article

A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa
A. Huttner, C. Combescure, S. Grillet, M. C. Haks, E. Quinten et al.
Science Translational Medicine, Journal article 2017
Journal article

Intradermal immunisation using the TLR3-ligand Poly (I:C) as adjuvant induces mucosal antibody responses and protects against genital HSV-2 infection
Emilie Bardel, Remi Doucet-Ladeveze, Cyrille Mathieu, Ali M Harandi, Bertrand Dubois et al.
npj Vaccines, Journal article 2016
Journal article

Toxin-Based Mucosal Adjuvants
Ali M Harandi, Nils Y Lycke
Immunopotentiators in Modern Vaccines (Second Edition), Chapter in book 2016
Chapter in book

Showing 11 - 20 of 45


Different human vaccine adjuvants promote distinct antigenin-dependent immunological signatures tailored to different pathogens
N. P. H. Knudsen, A. Olsen, C. Buonsanti, F. Follmann, Yuan Zhang et al.
Scientific Reports, Journal article 2016
Journal article


Ebola vaccine R&D: Filling the knowledge gaps
D. Medaglini, Ali M Harandi, T. H. M. Ottenhof, C. A. Siegrist
Science Translational Medicine, Journal article 2015
Journal article


Plant-Based Vaccines: Novel and Low-Cost Possible Route for Mediterranean Innovative Vaccination Strategies
A. A. E. Aboul-Ata, A. Vitti, M. Nuzzaci, A. K. El-Attar, G. Piazzolla et al.
Advances in Virus Research, San Diego, Elsevier Academic Press Inc, Review article 2014
Review article


Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens
F. Wegmann, K. H. Gartlan, Ali M Harandi, S. A. Brinckmann, M. Coccia et al.
Nature Biotechnology, Journal article 2012
Journal article



Mucosal adjuvants.
Ali M Harandi, Donata Medaglini
Current HIV research, Review article 2010
Review article

Showing 11 - 20 of 45

Page Manager: Webmaster|Last update: 4/19/2017

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?